531 related articles for article (PubMed ID: 26476374)
1. Quercetin reverses experimental pulmonary arterial hypertension by modulating the TrkA pathway.
He Y; Cao X; Liu X; Li X; Xu Y; Liu J; Shi J
Exp Cell Res; 2015 Nov; 339(1):122-34. PubMed ID: 26476374
[TBL] [Abstract][Full Text] [Related]
2. Involvement of Gax gene in hypoxia-induced pulmonary hypertension, proliferation, and apoptosis of arterial smooth muscle cells.
Xia S; Tai X; Wang Y; An X; Qian G; Dong J; Wang X; Sha B; Wang D; Murthi P; Kalionis B; Wang X; Bai C
Am J Respir Cell Mol Biol; 2011 Jan; 44(1):66-73. PubMed ID: 20160044
[TBL] [Abstract][Full Text] [Related]
3. Endothelin-1 driven proliferation of pulmonary arterial smooth muscle cells is c-fos dependent.
Biasin V; Chwalek K; Wilhelm J; Best J; Marsh LM; Ghanim B; Klepetko W; Fink L; Schermuly RT; Weissmann N; Olschewski A; Kwapiszewska G
Int J Biochem Cell Biol; 2014 Sep; 54():137-48. PubMed ID: 25016214
[TBL] [Abstract][Full Text] [Related]
4. Bioactive fraction of Rhodiola algida against chronic hypoxia-induced pulmonary arterial hypertension and its anti-proliferation mechanism in rats.
Nan X; Su S; Ma K; Ma X; Wang X; Zhaxi D; Ge R; Li Z; Lu D
J Ethnopharmacol; 2018 Apr; 216():175-183. PubMed ID: 29325918
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of caveolin-1 by DJ-1 attenuates rat pulmonary arterial hypertension by inhibiting TGFβ/Smad signaling pathway.
Gao W; Shao R; Zhang X; Liu D; Liu Y; Fa X
Exp Cell Res; 2017 Dec; 361(1):192-198. PubMed ID: 29069575
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of dioscin on vascular remodeling in pulmonary arterial hypertension via adjusting GRB2/ERK/PI3K-AKT signal.
Yang Y; Yin L; Zhu M; Song S; Sun C; Han X; Xu Y; Zhao Y; Qi Y; Xu L; Peng JY
Biomed Pharmacother; 2021 Jan; 133():111056. PubMed ID: 33378960
[TBL] [Abstract][Full Text] [Related]
7. CTRP9 regulates hypoxia-mediated human pulmonary artery smooth muscle cell proliferation, apoptosis and migration via TGF-β1/ERK1/2 signaling pathway.
Li YX; Run L; Shi T; Zhang YJ
Biochem Biophys Res Commun; 2017 Sep; 490(4):1319-1325. PubMed ID: 28688765
[TBL] [Abstract][Full Text] [Related]
8. Intermedin modulates hypoxic pulmonary vascular remodeling by inhibiting pulmonary artery smooth muscle cell proliferation.
Mao SZ; Fan XF; Xue F; Chen R; Chen XY; Yuan GS; Hu LG; Liu SF; Gong YS
Pulm Pharmacol Ther; 2014 Feb; 27(1):1-9. PubMed ID: 23796770
[TBL] [Abstract][Full Text] [Related]
9. [Effects of docosahexaenoic acid on hypoxia-induced pulmonary arterial hypertension].
Chen R; Liu P; Yan J; Gu Y
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Feb; 37(2):109-12. PubMed ID: 24796591
[TBL] [Abstract][Full Text] [Related]
10. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
[TBL] [Abstract][Full Text] [Related]
11. Bioactive Compounds From Coptidis Rhizoma Alleviate Pulmonary Arterial Hypertension by Inhibiting Pulmonary Artery Smooth Muscle Cells' Proliferation and Migration.
Luo S; Kan J; Zhang J; Ye P; Wang D; Jiang X; Li M; Zhu L; Gu Y
J Cardiovasc Pharmacol; 2021 Aug; 78(2):253-262. PubMed ID: 34554677
[TBL] [Abstract][Full Text] [Related]
12. PAR-2 inhibition reverses experimental pulmonary hypertension.
Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
[TBL] [Abstract][Full Text] [Related]
13. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
[TBL] [Abstract][Full Text] [Related]
14. Salidroside attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A2a receptor related mitochondria-dependent apoptosis pathway.
Huang X; Zou L; Yu X; Chen M; Guo R; Cai H; Yao D; Xu X; Chen Y; Ding C; Cai X; Wang L
J Mol Cell Cardiol; 2015 May; 82():153-66. PubMed ID: 25772255
[TBL] [Abstract][Full Text] [Related]
15. Isoquercitrin protects against pulmonary hypertension via inhibiting PASMCs proliferation.
Zhang Y; Cui Y; Deng W; Wang H; Qin W; Huang C; Li C; Zhang J; Guo Y; Wu D; Guo H
Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):362-370. PubMed ID: 27873355
[TBL] [Abstract][Full Text] [Related]
16. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871
[TBL] [Abstract][Full Text] [Related]
17. Exogenous spermine inhibits the proliferation of human pulmonary artery smooth muscle cells caused by chemically-induced hypoxia via the suppression of the ERK1/2- and PI3K/AKT-associated pathways.
Wei C; Li HZ; Wang YH; Peng X; Shao HJ; Li HX; Bai SZ; Lu XX; Wu LY; Wang R; Xu CQ
Int J Mol Med; 2016 Jan; 37(1):39-46. PubMed ID: 26572277
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
[TBL] [Abstract][Full Text] [Related]
19. Baicalin inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation via the AKT/HIF-1α/p27-associated pathway.
Zhang L; Pu Z; Wang J; Zhang Z; Hu D; Wang J
Int J Mol Sci; 2014 May; 15(5):8153-68. PubMed ID: 24821539
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment.
Veith C; Zakrzewicz D; Dahal BK; Bálint Z; Murmann K; Wygrecka M; Seeger W; Schermuly RT; Weissmann N; Kwapiszewska G
Thromb Haemost; 2014 Dec; 112(6):1288-303. PubMed ID: 25231004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]